About the Neurofibromatosis Program
The Neurofibromatosis Program at Children’s Hospital of Philadelphia (CHOP) is a multidisciplinary center for the diagnosis, surveillance and treatment of the complications of neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2).
One of the oldest programs in the United States, the CHOP neurofibromatosis clinic was founded in 1979 by Elaine Zackai, MD, Director of Clinical Genetics, and Anna Meadows, MD, Director of the Cancer Survivorship Program. Over the years, it has grown to involve a large team of dedicated physicians with multiple subspecialties including genetics, pediatrics, neuro-oncology, neuro-ophthalmology, ophthalmology orthopedics, and otolaryngology.
Depending upon the needs of the child many specialized services are also offered:
- Developmental Pediatrics
- Occupational Therapy
- Plastic Surgery
- Physical Therapy
- Speech Therapy
The neurofibromatosis team works closely with community pediatricians, schools and families to provide support and medical guidance for these children and families.